Comprehensive Cardiovascular Risk Assessment

Risk Factors and Assessment

The American College of Cardiology recommends evaluating for additional cardiovascular risk factors, such as hypertension, diabetes, smoking, and family history, and considering coronary computed tomography angiography (CCTA) to assess for non-calcified plaque and degree of stenosis 1, 2
The CAC score alone lacks important quantification of non-calcified plaque burden, according to the American College of Cardiology 1
Patients with inflammatory conditions may have a higher risk of cardiovascular events, even with the same CAC score, according to the American Heart Association and European Society of Cardiology 2, 3

The American Heart Association recommends a structured exercise program of at least 150 minutes of moderate-intensity activity weekly, a heart-healthy dietary pattern, such as the Mediterranean or DASH diet, and weight management for overweight or obese patients to reduce cardiovascular risk 3
Sodium reduction and dietary potassium supplementation are recommended for patients with hypertension 3
Smoking cessation is recommended as the highest priority for patients who smoke, as part of comprehensive lifestyle modifications, including 150 minutes of moderate-intensity exercise weekly, weight management, and consideration of low-dose aspirin for primary prevention in high-risk patients without high bleeding risk, according to the European Society of Cardiology and other guidelines 4, 5, 6, 7

A CAC score can significantly reclassify risk beyond traditional risk calculators, according to the American Heart Association 3

The risk categories associated with CAC scores are:

CAC Score	Risk Category
0	Low risk, annual mortality rate <0.5%, coronary event rate 0.4% over 3-5 years
1-99	Mild to moderate risk, 1.2-2.2 times higher risk of cardiovascular events
100-399	Moderate to high risk, 1.5-3.8 times higher risk (RR 4.3)
400 or higher	Severe to very high risk, 2.1-5.9 times higher risk (RR 7.2)
1000 or higher	Extremely high risk (RR 10.8)

Patients with Coronary Artery Calcium (CAC) scores ≥1000 have a relative risk of 10.8 for coronary heart disease death or myocardial infarction compared to those with CAC=0, with a pooled rate of CHD death or MI of approximately 7.1% over 3-5 years 9
A CAC score >100 is predictive of coronary heart disease, with patients having a 4.3 times higher risk of cardiovascular events compared to those with CAC=0, according to the American College of Radiology 10

The American College of Cardiology/American Heart Association (2019) and the Society of Cardiovascular Computed Tomography (2017) recommend CAC scoring for adults 40-75 years with intermediate ASCVD risk or selected adults with borderline risk when decisions about preventive interventions are uncertain 11
The American College of Cardiology recommends statin therapy when the CAC score is ≥100, regardless of other risk factors, as this threshold consistently identifies patients at high cardiovascular risk who benefit from statin therapy 7
If CAC score >0 or if risk-enhancing factors are present, initiate moderate-intensity statin therapy, with a target LDL-C reduction of ≥30% from baseline, as recommended by the American College of Cardiology 12
High-intensity statin therapy is recommended to reduce LDL-C by ≥50% for very high-risk patients, with consideration of adding ezetimibe if LDL-C goals are not achieved with statin alone, and PCSK9 inhibitors for those with inadequate LDL-C reduction, according to the European Society of Cardiology and the American College of Cardiology 8, 2, 5
If hypertension is present, initiate lifestyle modifications and pharmacotherapy as needed, with a target SBP of 120-129 mmHg if tolerated, according to the American College of Cardiology 13

The recommended follow-up intervals for CAC testing are:
CAC Score Repeat Interval
0 5-7 years
1-99 3-5 years
≥100 or diabetes 3 years
11, 7, 14
Regular monitoring of response to therapy with lipid profile and blood pressure checks is recommended, as stated by the European Heart Journal and the American College of Cardiology guidelines 4, 8, 2

Relying solely on traditional risk calculators can be misleading, as they are strong population-based markers but poor individual discriminators of coronary atherosclerotic disease, according to the European Society of Cardiology and other guidelines 10
Overlooking subclinical atherosclerosis, neglecting lifestyle modifications, and missing risk-enhancing factors can all lead to inadequate risk assessment and management, as recommended by the American College of Cardiology and other guidelines 10, 12, 13
Delaying preventive therapy can result in reduced mortality and morbidity benefits, according to the European Society of Cardiology and other guidelines 10